Spedra (avanafil)
- Region
- 🇪🇺 EU
- Active substance
- avanafil
- Company
- Phoenix Labs Unlimited Company
- Status
- Authorised
- Therapeutic area
- Erectile Dysfunction
- EU approval
- Fri 21 Jun 2013
- Application
- EMEA/H/C/002581
- ATC
- G04BE10
- Official record
- www.ema.europa.eu
Indication
Treatment of erectile dysfunction in adult men. In order for Spedra to be effective, sexual stimulation is required.
Regulatory milestones
No milestones recorded in the last year.
Follow Spedra
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.